Seralutinib [CAS 1619931-27-9]
Partner: MedChemexpress LLC
| CAS No: | 1619931-27-9 |
| Applications: | Neuroscience-Neuromodulation |
| MW: | 469.53 |
| Formula: | C27H27N5O3 |
| SMILES: | O=C(C1=CC(C)=CN=C1)NC2=CC=CC([C@@H](NC3=NC(C4=CC=C(OC)C(OC)=C4)=CN=C3)C)=C2 |
| Purity: | 99.77 |
| Description: | Seralutinib (GB002) is an inhaled PDGFR? and PDGFR? inhibitor. Seralutinib also targets to CSF1R and c-KIT with IC50s of 8 nM and 14 nM, respectively. Seralutinib (GB002) is used in the study for pulmonary arterial hypertension[1][2]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
